Ramesh Duwa

430 total citations
16 papers, 323 citations indexed

About

Ramesh Duwa is a scholar working on Biomaterials, Biomedical Engineering and Immunology. According to data from OpenAlex, Ramesh Duwa has authored 16 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomaterials, 7 papers in Biomedical Engineering and 6 papers in Immunology. Recurrent topics in Ramesh Duwa's work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Ramesh Duwa is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Ramesh Duwa collaborates with scholars based in South Korea, United States and Philippines. Ramesh Duwa's co-authors include Simmyung Yook, Jee‐Heon Jeong, Sooyeun Lee, Asmita Banstola, Fakhrossadat Emami, Sunil Bhurtel, Dong‐Young Choi, Nikita Katila, Taeg Kyu Kwon and Jae‐Hoon Chang and has published in prestigious journals such as Biomaterials, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Ramesh Duwa

16 papers receiving 322 citations

Peers

Ramesh Duwa
M. P. Valikhov Russia
Romain Brusini France
Junning Ma United States
Junxiao Gao China
Maosen Han China
Hongzhi Xu China
Bhabani Mohanty India
Zhongyue Yuan China
Catarina Pacheco Portugal
Xiao Du China
M. P. Valikhov Russia
Ramesh Duwa
Citations per year, relative to Ramesh Duwa Ramesh Duwa (= 1×) peers M. P. Valikhov

Countries citing papers authored by Ramesh Duwa

Since Specialization
Citations

This map shows the geographic impact of Ramesh Duwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramesh Duwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramesh Duwa more than expected).

Fields of papers citing papers by Ramesh Duwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramesh Duwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramesh Duwa. The network helps show where Ramesh Duwa may publish in the future.

Co-authorship network of co-authors of Ramesh Duwa

This figure shows the co-authorship network connecting the top 25 collaborators of Ramesh Duwa. A scholar is included among the top collaborators of Ramesh Duwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramesh Duwa. Ramesh Duwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Varniab, Zahra Shokri, Edwin Chang, Jie Wang, et al.. (2025). Dual-enzyme activated theranostic nanoparticles for image-guided glioblastoma therapy. Scientific Reports. 15(1). 13540–13540. 2 indexed citations
2.
Duwa, Ramesh, et al.. (2024). ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A. European Journal of Pharmaceutical Sciences. 201. 106856–106856. 8 indexed citations
3.
Duwa, Ramesh, Lyndon D. Bastatas, Youngdae Gwon, et al.. (2024). Strengthened binding affinity of bispecific antibody nanoplatforms improved the anti-tumor efficacy. Chemical Engineering Journal. 494. 153128–153128. 1 indexed citations
4.
5.
Woo, Seon Min, Seung Un Seo, Asmita Banstola, et al.. (2024). Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer. Biomaterials. 312. 122733–122733. 13 indexed citations
6.
Duwa, Ramesh, Sooyeun Lee, Taeg Kyu Kwon, et al.. (2024). Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy. Journal of Controlled Release. 372. 587–608. 21 indexed citations
7.
Emami, Fakhrossadat, Ramesh Duwa, Asmita Banstola, et al.. (2023). Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy. Biomedicine & Pharmacotherapy. 165. 115023–115023. 16 indexed citations
8.
Duwa, Ramesh, Asmita Banstola, Mahesh Pandit, et al.. (2022). T-cell engaging poly(lactic-co-glycolic acid) nanoparticles as a modular platform to induce a potent cytotoxic immunogenic response against PD-L1 overexpressing cancer. Biomaterials. 291. 121911–121911. 23 indexed citations
9.
Banstola, Asmita, Mahesh Pandit, Ramesh Duwa, et al.. (2022). Reactive oxygen species‐responsive dual‐targeted nanosystem promoted immunogenic cell death against breast cancer. Bioengineering & Translational Medicine. 8(5). e10379–e10379. 7 indexed citations
10.
Katila, Nikita, Ramesh Duwa, Sunil Bhurtel, et al.. (2022). Enhancement of blood–brain barrier penetration and the neuroprotective effect of resveratrol. Journal of Controlled Release. 346. 1–19. 71 indexed citations
11.
Emami, Fakhrossadat, et al.. (2022). Triple-negative breast cancer treatment meets nanoparticles: Current status and future direction. Journal of Drug Delivery Science and Technology. 71. 103274–103274. 7 indexed citations
12.
Duwa, Ramesh, Jee‐Heon Jeong, & Simmyung Yook. (2021). Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson’s disease. Journal of Pharmaceutical Investigation. 51(4). 465–481. 20 indexed citations
13.
Duwa, Ramesh, Jee‐Heon Jeong, & Simmyung Yook. (2020). Immunotherapeutic strategies for the treatment of ovarian cancer: current status and future direction. Journal of Industrial and Engineering Chemistry. 94. 62–77. 12 indexed citations
14.
15.
Duwa, Ramesh, Asmita Banstola, Fakhrossadat Emami, et al.. (2020). Cetuximab conjugated temozolomide-loaded poly (lactic-co-glycolic acid) nanoparticles for targeted nanomedicine in EGFR overexpressing cancer cells. Journal of Drug Delivery Science and Technology. 60. 101928–101928. 47 indexed citations
16.
Duwa, Ramesh, Fakhrossadat Emami, Sooyeun Lee, Jee‐Heon Jeong, & Simmyung Yook. (2019). Polymeric and lipid-based drug delivery systems for treatment of glioblastoma multiforme. Journal of Industrial and Engineering Chemistry. 79. 261–273. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. P. Valikhov Breakdown of academic impact, for papers by Romain Brusini Breakdown of academic impact, for papers by Junning Ma Breakdown of academic impact, for papers by Junxiao Gao Breakdown of academic impact, for papers by Maosen Han Breakdown of academic impact, for papers by Hongzhi Xu Breakdown of academic impact, for papers by Bhabani Mohanty Breakdown of academic impact, for papers by Zhongyue Yuan Breakdown of academic impact, for papers by Catarina Pacheco Breakdown of academic impact, for papers by Xiao Du
Rankless by CCL
2026